CSPC Pharmaceutical Group Limited (CVG) - Total Liabilities

Latest as of December 2025: €12.15 Billion EUR ≈ $14.20 Billion USD

Based on the latest financial reports, CSPC Pharmaceutical Group Limited (CVG) has total liabilities worth €12.15 Billion EUR (≈ $14.20 Billion USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

CSPC Pharmaceutical Group Limited - Total Liabilities Trend (2013–2025)

This chart illustrates how CSPC Pharmaceutical Group Limited's total liabilities have evolved over time, based on quarterly financial data. See how liquid is CSPC Pharmaceutical Group Limited's working capital to evaluate short-term liquidity relative to the company's equity base.

CSPC Pharmaceutical Group Limited Competitors by Total Liabilities

The table below lists competitors of CSPC Pharmaceutical Group Limited ranked by their total liabilities.

Company	Country	Total Liabilities
Gildan Activewear Inc. TO:GIL	Canada	CA$7.07 Billion
James Hardie Industries plc F:JHA	Germany	€7.41 Billion
Smithfield Foods, Inc. Common Stock NASDAQ:SFD	USA	$4.80 Billion
D'Ieteren Group SA BR:DIE	Belgium	€6.72 Billion
Yangzhou Yangjie Electronic Technology Co Ltd SHE:300373	China	CN¥6.67 Billion
Allison Transmission Holdings Inc NYSE:ALSN	USA	$6.85 Billion
Barito Pacific Tbk JK:BRPT	Indonesia	Rp8.98 Billion
China Eastern Airlines Corp Ltd SHG:600115	China	CN¥256.87 Billion

Liability Composition Analysis (2013–2025)

This chart breaks down CSPC Pharmaceutical Group Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see CSPC Pharmaceutical Group Limited (CVG) market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.19	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.37	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.26	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how CSPC Pharmaceutical Group Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for CSPC Pharmaceutical Group Limited (2013–2025)

The table below shows the annual total liabilities of CSPC Pharmaceutical Group Limited from 2013 to 2025.

Year	Total Liabilities	Change
2025-12-31	€12.15 Billion ≈ $14.20 Billion	+15.44%
2024-12-31	€10.52 Billion ≈ $12.30 Billion	-6.58%
2023-12-31	€11.26 Billion ≈ $13.17 Billion	+11.22%
2022-12-31	€10.13 Billion ≈ $11.84 Billion	+27.99%
2021-12-31	€7.91 Billion ≈ $9.25 Billion	+13.55%
2020-12-31	€6.97 Billion ≈ $8.15 Billion	+2.48%
2019-12-31	€6.80 Billion ≈ $7.95 Billion	-11.36%
2018-12-31	€7.67 Billion ≈ $8.97 Billion	+49.65%
2017-12-31	€5.13 Billion ≈ $5.99 Billion	+25.32%
2016-12-31	€4.09 Billion ≈ $4.78 Billion	-13.46%
2015-12-31	€4.73 Billion ≈ $5.53 Billion	+8.68%
2014-12-31	€4.35 Billion ≈ $5.09 Billion	-5.52%
2013-12-31	€4.60 Billion ≈ $5.38 Billion	--

About CSPC Pharmaceutical Group Limited

F:CVG Germany Drug Manufacturers - General

Market Cap

$9.80 Billion

€8.38 Billion EUR

Market Cap Rank

#2302 Global

#470 in Germany

Share Price

€0.73

Change (1 day)

-1.09%

52-Week Range

€0.73 - €1.25

All Time High

€1.25